Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae

By sjmartinez • August 5, 2023

Maas L, Gao R, Cusumano V, Spartz E, Chowdhury R, Krishna M, Lazarev M, Melia J, Selaru F, Sharma S, Limketkai B, Parian A. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae. Dig Dis Sci. 2023 Aug 4. doi: 10.1007/s10620-023-08060-7. Epub ahead of print. PMID: 37540392.

Tags: Crohn’s disease, Digestive Diseases, General Internal Medicine, inflammatory bowel disease, Perianal disease, Perianal fistula, Publications, Resident, Tumor necrosis factor inhibitor

New Basic Science Editor and New Journal Management Committee Chair of Neurogastroenterology and Motility!

Corsetti M, Zerbib F, Black C, Shin A, Browning K, Keszthelyi D, Jones M. New Basic Science Editor and New Journal Management Committee Chair of[...]

Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta-Analysis

Maniyar I, Jajoo A, Brewer GG, Iyengar P, Nguyen A, Fasulo C, White J, Parian A, Limketkai BN. Dietary Sugar and Sweetened Beverage Intake Increases[...]

Endoscopic Sleeve Gastroplasty is an Effective Treatment for Obesity in a Veteran With Metabolic and Psychiatric Comorbidities

Kozan P, Kashefi M, Romanova M, Kolb JM. Endoscopic Sleeve Gastroplasty is an Effective Treatment for Obesity in a Veteran With Metabolic and Psychiatric Comorbidities.[...]